Pharmacologic management of perioperative pulmonary hypertension.
Date
2014-04
Journal Title
Journal ISSN
Volume Title
Citation Stats
Attention Stats
Abstract
Perioperative pulmonary hypertension can originate from an established disease or acutely develop within the surgical setting. Patients with increased pulmonary vascular resistance are consequently at greater risk for complications. Despite the various specific therapies available, the ideal therapeutic approach in this patient population is not currently clear. This article describes the basic principles of perioperative pulmonary hypertension and reviews the different classes of agents used to promote pulmonary vasodilation in the surgical setting.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Cheng, Julie W, Adriano R Tonelli, Gosta Pettersson and Richard A Krasuski (2014). Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol, 63(4). pp. 375–384. 10.1097/FJC.0000000000000050 Retrieved from https://hdl.handle.net/10161/10989.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Richard Andrew Krasuski
Dr. Richard Krasuski is an Adjunct Professor of Medicine and Pediatrics at Duke University Medical Center. He was formerly the Director of the Adult Congenital Heart Center, Director of Hemodynamic Research, and the Medical Director of the CTEPH Program at Duke. He is considered a thought leader in the fields of pulmonary hypertension and congenital heart disease. His research focus is in epidemiologic and clinical studies involving patients with pulmonary hypertension and patients with congenital heart disease. He is involved in multiple multicenter studies through the Alliance for Adult Research in Congenital Cardiology (AARCC). He has also helped to develop multiple research databases in these patient populations. He is Co-PI in the EPIPHANY Study examining the impact of medical and transcatheter interventions on RV-PA coupling in patients with chronic thromboembolic pulmonary hypertension. Over his career he has mentored over 100 students, residents and fellows and has published over 350 peer reviewed articles, book chapters and meeting abstracts. He is also the Chief Editor of Advances in Pulmonary Hypertension and on the editorial boards of >20 leading medical journals. He has been an invited speaker at over 100 medical centers worldwide.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.